BridgeMD
New treatment option for Recurrent Prostate Cancer After Surgery
Official title This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
ClinicalTrials.gov ID: NCT05946824
What this study is testing
- What it's testing
- There is significant, proven use of radiation for recurrent prostate cancer after surgical resection. This treatment typically is delivered over seven and a half weeks of daily treatments, presenting a burden to patients and the health care system.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only. Healthy volunteers may be eligible.
You may be able to join if
- Adenocarcinoma of the prostate with previous surgical resection
- Radiologically detected prostate bed OR regional nodal recurrence defined as iliac, obturator, perirectal or pre-sacral node generally encompassing...
- Prostate bed recurrence as occurring within the region of the prostate or RTOG consensus definition of the surgical field
- At least two serum detectable PSA levels defined as \>0.02 ng/dl at least 30 days apart.
You likely can't join if
- Metastatic disease
- Prior radiation therapy to the pelvis region
- Inflammatory bowel disease
- Hospitalization for a gastrointestinal diagnosis in the preceeding 3 months
- Hospitalization for a urinary tract issue / diagnosis in the preceeding 3 months
- PSA \>10 ng/dl at study entry,
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.